Literature DB >> 11856632

Perceptual and motor contributions to performance and ERP components after incorrect motor activation in a flanker reaction task.

Dennis Van 't Ent1.   

Abstract

OBJECTIVES: The aims of this study are to evaluate contributions of response and perceptual processes to reaction performance in a flanker reaction task, and to investigate whether event-related potential (ERP) component N2 and error negativity N(e) represent similar or functionally distinct cortical mechanisms.
METHODS: ERPs, lateralized readiness potentials (LRPs) and reaction performance were measured in a flanker task with arrows as targets and congruent or incongruent flankers. Squares were used as neutral flankers. Target color signaled a response of the hand indicated by (PRO) or against (ANTI) the target arrow's pointing direction.
RESULTS: On both PRO and ANTI conditions, performance was facilitated by congruent and impaired by incongruent flankers. In the ERPs on trials with late response errors an N2 was evident before an N(e). In addition, ERPs on correct trials showed an N2 particularly after incongruent flankers on PRO but for each flanker type on ANTI conditions. On incongruent ANTI trials, two successive response conflicts occurred but only a single N2 appeared.
CONCLUSIONS: The results indicate that differences in perceptual processing contribute significantly to the flanker effects on task performance and provide further evidence that N2 and N(e) represent different cortical mechanisms. The data also suggest that N2 is not a real-time correlate of incorrect response suppression.

Mesh:

Year:  2002        PMID: 11856632     DOI: 10.1016/s1388-2457(01)00730-1

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

1.  Individual differences discriminate event-related potentials but not performance during response inhibition.

Authors:  Richard A P Roche; Hugh Garavan; John J Foxe; Shane M O'Mara
Journal:  Exp Brain Res       Date:  2005-01       Impact factor: 1.972

2.  Flanker compatibility effects in patients with Parkinson's disease: impact of target onset delay and trial-by-trial stimulus variation.

Authors:  Xavier E Cagigas; J Vincent Filoteo; John L Stricker; Laurie M Rilling; Frances J Friedrich
Journal:  Brain Cogn       Date:  2006-10-17       Impact factor: 2.310

3.  Functional connectivity in frontostriatal networks differentiate offspring of parents with substance use disorders from other high-risk youth.

Authors:  Elizabeth Kwon; Tom Hummer; Katharine D Andrews; Peter Finn; Matthew Aalsma; Allen Bailey; Jocelyne Hanquier; Ting Wang; Leslie Hulvershorn
Journal:  Drug Alcohol Depend       Date:  2020-12-31       Impact factor: 4.492

4.  Neural Processing of Cognitive Control in an Emotionally Neutral Context in Anxiety Patients.

Authors:  Nicola König; Sarah Steber; Anna Borowski; Harald R Bliem; Sonja Rossi
Journal:  Brain Sci       Date:  2021-04-26

5.  A preliminary randomized, controlled trial of executive function training for children with autism spectrum disorder.

Authors:  Susan Faja; Tessa Clarkson; Rachel Gilbert; Akshita Vaidyanathan; Gabriella Greco; M Rosario Rueda; Lina M Combita; Kate Driscoll
Journal:  Autism       Date:  2021-09-02

6.  Evaluative priming in a semantic flanker task: ERP evidence for a mutual facilitation explanation.

Authors:  Melanie Schmitz; Dirk Wentura; Thorsten A Brinkmann
Journal:  Cogn Affect Behav Neurosci       Date:  2014-03       Impact factor: 3.526

7.  Conflict-Specific Aging Effects Mainly Manifest in Early Information Processing Stages-An ERP Study with Different Conflict Types.

Authors:  Margarethe Korsch; Sascha Frühholz; Manfred Herrmann
Journal:  Front Aging Neurosci       Date:  2016-03-16       Impact factor: 5.750

8.  The Effects of Aging and Time of Day on Inhibitory Control: An Event-Related Potential Study.

Authors:  Rahel Rabi; Ricky Chow; Shahier Paracha; Lynn Hasher; Sandra Gardner; Nicole D Anderson; Claude Alain
Journal:  Front Aging Neurosci       Date:  2022-03-11       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.